a Professor, NESMOS (Neuroscience, Mental Health, and Sensory Organs) Department , Sapienza-University of Rome , Rome , Italy.
b Resident, Department of Psychiatry , San Maurizio Hospital, Sanitary Agency of South Tyrol , Bolzano-Bozen , Italy.
J Psychoactive Drugs. 2017 Nov-Dec;49(5):373-384. doi: 10.1080/02791072.2017.1359708. Epub 2017 Aug 4.
The use of performance and image enhancing drugs (PIEDs) is not uncommon in athletes and appears to be associated with several psychopathological disorders of unclear prevalence. In this multicenter, cross-sectional study, we aimed to evaluate the prevalence of body image disorders (BIDs) and eating disorders (EDs) in PIED-using athletes vs. PIED nonusers. We enrolled 84 consecutive professional and amateur athletes training in sport centers in Italy, who underwent semi-structured interviews (SCID-I, SCID-II) and completed the Body Image Concern Inventory (BICI) and the Sick, Control, One, Fat, Food Eating Disorder Screening Test (SCOFF). PIEDs were searched for in participants' blood, urine, and hair. Of these, 18 (21.4%) used PIEDs, the most common being anabolic androgenic steroids, amphetamine-like substances, coffee and caffeine derivatives, synthetic cathinones, and ephedrine. PIED users and nonusers did not differ in socio-demographic characteristics, but differed in clinical and psychopathological features, with PIED users being characterized by higher physical activity levels, higher daily coffee and psychotropic medication use (e.g., benzodiazepines), more SCID diagnoses of psychiatric disorders, especially substance use disorder, body dysmorphic disorder (BDD), EDs, and general anxiety disorder, higher BICI scores (indicating higher risk of BDD), and higher SCOFF scores (suggesting higher risks for BIDs and EDs).
运动员中使用表现和形象增强药物(PIEDs)并不罕见,似乎与几种精神病理学紊乱有关,其流行程度尚不清楚。在这项多中心、横断面研究中,我们旨在评估使用 PIED 的运动员与未使用 PIED 的运动员之间的体像障碍(BID)和饮食障碍(ED)的患病率。我们招募了 84 名连续的专业和业余运动员,他们在意大利的运动中心接受了半结构化访谈(SCID-I、SCID-II),并完成了体像关注量表(BICI)和疾病、控制、一个、肥胖、食物饮食障碍筛查测试(SCOFF)。在参与者的血液、尿液和头发中搜索 PIEDs。其中 18 名(21.4%)使用了 PIEDs,最常见的是合成代谢雄激素类固醇、苯丙胺类物质、咖啡和咖啡因衍生物、合成卡西酮和麻黄碱。PIED 用户和非用户在社会人口统计学特征上没有差异,但在临床和精神病理学特征上存在差异,PIED 用户的身体活动水平更高,每日咖啡和精神药物使用量更高(例如,苯二氮䓬类药物),SCID 诊断的精神障碍更多,尤其是物质使用障碍、体像障碍(BDD)、ED 和广泛性焦虑障碍,BICI 评分更高(表明 BDD 风险更高),SCOFF 评分更高(表明 BID 和 ED 的风险更高)。